Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis

Annals of Neurology

Volumn 28, Issue 1, 1990, Pages 18-25

  Rothstein, Jeffrey D ^a   Tsai, Guochuan ^a   Kuncl, Ralph W ^a   Clawson, Lora ^a   Cornblath, David R ^a   Drachman, Daniel B ^a   Pestronk, Alan ^a   Stauch, Barbara L ^a   Coyle, Joseph T ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXCITATORY AMINO ACID; GLUTAMIC ACID; N ACETYLASPARTIC ACID; N ACETYLASPARTYLGLUTAMIC ACID;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MOTOR NEURON DISEASE; PRIORITY JOURNAL;

ADULT; AGED; AMINO ACIDS; AMYOTROPHIC LATERAL SCLEROSIS; ASPARTIC ACID; DIPEPTIDES; FEMALE; GLUTAMATES; HUMAN; MALE; MIDDLE AGE; SPINAL CORD; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025299819     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410280106     Document Type: Article

References (58)

1. Glutamate dehydrogenase deficiency in three patients with spinocerebellar syndrome
2. Degenerative neurological disorders associated with a deficiency of glutamate dehydrogenase
3. Huntington's disease. Pathogenesis and management
4. Huntington's disease
5. Brain lesions, obesity and other disturbances in mice treated with monosodium glutamate
6. Excitotoxins
7. Synaptic release of excitatory amino acid neurotransmitter mediates anoxis neuronal death
8. Neurotoxic action of kainic acid
9. Guam ALS/parkinsonism‐dementia: a long‐latency neurotoxic disorder caused by “slow toxin(s)” in food?
10. Guam amyotrophic lateral sclerosis‐parkinsonism‐dementia linked to a plant excitant neurotoxin
11. Elevated levels of amino acids in the CSF of motor neuron disease patients
12. Free amino acid levels in amyotrophic lateral sclerosis
13. Brain glutamate deficiency in amyotrophic lateral sclerosis
14. The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis
15. N‐Acetylaspartate and N‐acetylaspartylglutamate are altered in the spinal cord in amyotrophic lateral sclerosis
16. Free amino acids in motor neuron cortex in amyotrophic lateral sclerosis
17. Electromyography in amyotrophic lateral sclerosis
18. Cerebrospinal fluid glutamine as a measure of hepatic encephalopathy
19. Methods for assessing hepatic encephalopathy
20. Protein measurement with the Folin phenol reagent
21. Hydrolysis of the dipeptide N‐acetyl‐aspartyl‐L‐glutamate
22. Hydrolysis of the brain dipeptide N‐acetyl‐L‐glutamate: subcellular and regional distribution, ontogeny, and the effect of lesions on N‐acetylated‐α‐linked acidic dipeptidase activity
23. The distribution of glutamate dehydrogenase in rat tissues: isotopic vs. fluorimetric assays
24. CSF amino acids and plasma‐CSF amino acid ratios in adults
25. The free amino acids in human cerebrospinal fluid
26. Plasma amino acid patterns in hepatic encephalopathy of differing etiology
27. Chemical changes in spinal cord in Friedreich's ataxia and motor neuron disease
28. Abnormal glutamate metabolism in amyotrophic lateral sclerosis
29. Glutamate dehydrogenase and aspartate aminotransferase in leukocytes of petients with motor neuron disease
30. Changes in free amino acids of cerebrospinal fluid and plasma in various neurological diseases
31. Quantitation of N‐acetyl‐aspartyl‐glutamate in microdissected brain nuclei and peripheral tissues: findings with a novel liquid phase radioimmunoassay
32. N‐Acetylaspartylglutamate: an endogenous peptide with high affinity for brain “glutamate” receptor
33. The neurobiology of N‐acetyl‐aspartyl glutamate
34. Neurochemical and immunocytochemical studies on the distribution of N‐acetyl‐aspartylglutamate and N‐acetyl‐aspartate in rat spinal cord and some peripheral tissues
35. Selective immunocytochemical staining of mitral cells in rat olfactory bulb with purified antibodies against N‐acetyl‐aspartyl‐glutamate
36. Ultrastructural localization of N‐acetylaspartylglutamate in synaptic vesicles or retinal neurons
37. Co‐localization of N‐acetyl‐aspartylglutamate in central cholinergic, noradrenergic, and serotonergic neurons
38. 3H]acetylaspartylglutamate from the optic pathway
39. Calcium‐dependent release of N‐acetylaspartylglutamate from retinal neurons upon depolarization
40. Release of N‐acetylaspartylglutamate on depolarization of rat brain slices
41. Dipeptides of glutamate and aspartate may be endogenous neuroexcitants in the rat hippocampal slice
42. Regional distribution of cholinergic neurons in human spinal cord transections in patients with and without motor neuron disease
43. Choline acetyltransferase and substance P‐like immunoreactivity in human spinal cord: cord changes in amyotrophic lateral sclerosis
44. Elevation of extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis
45. Gangliosides prevent glutamate and kainate neurotoxicity in primary neuronal cultures of neonatal rat cerebellum and cortex
46. Alteration of striatal glutamate release after glutamine synthetase inhibition
47. Glial and neuronal transport following glutamine synthetase inhibition
48. A simulation study of brain compartments. Metabolism of glutamate and related substances in mouse brain
49. Functional interactions between neurons and astrocytes. I. Turnover and metabolism of putative amino acid transmitters
50. Metabolic compartmentation of the glutamate‐glutamine system: glial contribution
51. Free amino acids in the cerebrospinal fluid in old age and in Parkinson's disease
52. Amino acid abnormalities in cerebrospinal fluid of patients with parkinsonism and extrapyramidal disorders
53. Cerebrospinal fluid amino compounds in Parkinson's disease
54. Free and conjugated amino acids in human CSF: influence of age and sex
55. Pilot trial of branched‐chain aminoacids in amyotrophic lateral sclerosis
56. Asparto‐acylase deficiency and N‐acetylaspartic aciduria in patients with Canavan disease
57. Neurotoxicity of B‐N‐methylamino‐L‐alanine (BMAA) and B‐N‐oxalylamino‐L‐alanine (BOAA) on cultured cortical neurons